Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	102.75	127.67	135.55	66.33	77.62	76.19
Short-Term Investments	239.48	255.67	232.67	365.34	145.92	364.51
Cash & Short-Term Investments	342.23	383.33	368.22	431.67	223.54	440.7
Cash Growth	-27.67%	4.10%	-14.70%	93.11%	-49.28%	59.69%
Accounts Receivable	64.57	53.98	41.12	31.06	27.63	26.2
Other Receivables	-	-	14	15.8	1.4	1.3
Receivables	64.57	53.98	55.12	46.86	29.03	27.5
Inventory	12.28	12.41	7.73	6.1	4.99	4.91
Prepaid Expenses	9.69	9.49	4.32	14.62	8.92	5.4
Other Current Assets	14.35	12.39	23.24	-	-	-
Total Current Assets	443.11	471.6	458.64	499.25	266.46	478.5
Property, Plant & Equipment	7.31	8.01	0.32	1.78	1.52	4.18
Long-Term Investments	172.78	219.83	57.18	4.95	112.28	36.2
Long-Term Deferred Tax Assets	162.23	130.91	90.61	61.47	27.46	31.6
Other Long-Term Assets	16.29	10.19	14.79	15.99	16.05	21.25
Total Assets	801.72	840.55	621.52	583.43	423.76	571.73
Accounts Payable	23.53	15.38	17.4	11.98	6.91	10.55
Accrued Expenses	113.24	122.11	70.49	44.52	39.3	34.69
Current Portion of Leases	1.02	0.83	0.15	1.14	0.53	2.05
Current Income Taxes Payable	-	0.19	1.81	0.09	0.51	-
Other Current Liabilities	6.88	2.27	14.65	14.76	0.3	0.2
Total Current Liabilities	144.66	140.77	104.51	72.49	47.54	47.49
Long-Term Leases	5.59	6.11	-	-	-	0.5
Other Long-Term Liabilities	15.68	14.08	10.31	9.1	0.41	0.4
Total Liabilities	165.93	160.96	114.81	81.59	47.95	48.39
Common Stock	0.14	0.14	0.13	0.13	0.13	0.12
Additional Paid-In Capital	900.86	832.11	738.52	662.34	591.35	516.14
Retained Earnings	599.43	543.74	402.53	296.39	194.97	82.46
Treasury Stock	-866.93	-696.17	-635.08	-456.15	-410.41	-75.8
Comprehensive Income & Other	2.29	-0.22	0.61	-0.87	-0.23	0.42
Shareholders' Equity	635.79	679.59	506.71	501.84	375.81	523.34
Total Liabilities & Equity	801.72	840.55	621.52	583.43	423.76	571.73
Total Debt	6.61	6.94	0.15	1.14	0.53	2.55
Net Cash (Debt)	508.4	596.23	425.25	435.48	335.29	474.34
Net Cash Growth	4.44%	40.21%	-2.35%	29.88%	-29.32%	52.10%
Net Cash Per Share	4.30	5.25	3.81	3.76	2.66	3.82
Filing Date Shares Outstanding	105.37	105.5	103.52	107.9	105.96	117.31
Total Common Shares Outstanding	105.29	105.11	103.41	107.84	105.94	116.74
Working Capital	298.45	330.83	354.13	426.76	218.92	431.01
Book Value Per Share	6.04	6.47	4.90	4.65	3.55	4.48
Tangible Book Value	635.79	679.59	506.71	501.84	375.81	523.34
Tangible Book Value Per Share	6.04	6.47	4.90	4.65	3.55	4.48
Machinery	-	-	-	-	1.16	0.81
Leasehold Improvements	-	-	-	-	1.26	1.23

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q